Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)

CUSIP: 83086J200

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
33,945,050
Total 13F shares
24,700,100
Share change
-477,593
Total reported value
$39,307,441
Put/Call ratio
25%
Price per share
$1.59
Number of holders
72
Value change
-$1,237,638
Number of buys
27
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 83086J200?
CUSIP 83086J200 identifies SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q1 2025

As of 31 Mar 2025, Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,700,100 shares. The largest 10 holders included 5AM Venture Management, LLC, Versant Venture Management, LLC, Schonfeld Strategic Advisors LLC, SPHERA FUNDS MANAGEMENT LTD., BAKER BROS. ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, Altium Capital Management LLC, BRAIDWELL LP, and Ensign Peak Advisors, Inc. This page lists 72 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.